Search Results
JEL Code: L65

212,885 Total downloads

Viewing: 1 - 50 of 788 papers

1.

Killer Acquisitions

Journal of Political Economy, Vol. 129, No. 3, pp. 649–702, March 2021
Number of pages: 97 Posted: 12 Sep 2018 Last Revised: 02 May 2021
Accepted Paper Series
University of Utah - Department of Entrepreneurship & Strategy, Boston University - Markets, Public Policy, and Law and Yale School of Management
Downloads 14,252
2.

Drugged Out: How Cognitive Bias Hurts Drug Innovation

51 San Diego Law Review 419 (2014)
Number of pages: 90 Posted: 01 Sep 2013 Last Revised: 09 Aug 2014
Accepted Paper Series
Loyola University of Chicago School of Law
Downloads 11,401
3.

The Effects of Service Quality and Word of Mouth on Customer Acquisition, Retention and Usage

Number of pages: 48 Posted: 11 Mar 2007
Working Paper Series
City University of Hong Kong, University of Michigan, Stephen M. Ross School of Business and University of Chicago
Downloads 4,292
4.

Unpatentable Drugs and the Standards of Patentability

Texas Law Review, Vol. 87, pp. 503-570, 2009
Number of pages: 68 Posted: 04 May 2008 Last Revised: 02 Jun 2013
Accepted Paper Series
affiliation not provided to SSRN
Downloads 2,259
5.

Forecasting Market Share in the US Pharmaceutical Market

Nature Reviews Drug Discovery. 2015. Vol. 14, No. 9: 594-595
Number of pages: 19 Posted: 18 Apr 2016
Accepted Paper Series
Novartis International AG and Duke University - Fuqua School of Business
Downloads 1,723
6.

Pharmaceutical Development Phases: A Duration Analysis

FTC, Bureau of Economics Working Paper No. 274
Number of pages: 30 Posted: 25 Oct 2004
Working Paper Series
Berkeley Research Group, LLC, CBO and Berkeley Research Group, LLC
Downloads 1,690
7.

Business Model Innovation in the Pharmaceutical Industry: The Supporting Role of Organizational Design

Number of pages: 32 Posted: 25 Feb 2014
Working Paper Series
Copenhagen Business School - Department of Strategy and Innovation and Copenhagen Business School
Downloads 1,367
8.

Common Ownership and Market Entry: Evidence from Pharmaceutical Industry

DIW Berlin Discussion Paper No. 1738
Number of pages: 66 Posted: 26 Jun 2018 Last Revised: 28 Jul 2022
Working Paper Series
ETH Zürich - CER-ETH - Center of Economic Research at ETH Zurich, KU Leuven - Faculty of Business and Economics (FEB) and City University London - Department of EconomicsUniversitat Pompeu Fabra - Department of Economics and Business (DEB)
Downloads 1,341
9.

The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines Under the Amended TRIPS Provisions

Journal of International Economic Law, Vol. 10, pp. 921-87, 2007, FSU College of Law, Law and Economics Paper No. 07-25, FSU College of Law, Public Law Research Paper No. 287
Number of pages: 68 Posted: 01 Nov 2007 Last Revised: 01 May 2013
Accepted Paper Series
Florida State University - College of Law and Duke University School of Law
Downloads 1,322
10.

The Great Global Vitamins Cartels

Number of pages: 190 Posted: 28 Feb 2006 Last Revised: 15 May 2008
Working Paper Series
Purdue UniversityAmerican Antitrust Institute (AAI)
Downloads 1,321
11.

Recycling of Used Engine Oil for Cooking Fuel Using Solar Thermal Pyrolysis

Number of pages: 78 Posted: 07 Dec 2020
Working Paper Series
Jimma University, Jimma University (JU) - Faculty of Mechanical Engineering and Jimma University
Downloads 1,312
12.

Pioneering Advantage in Generic Drug Competition

International Journal of Pharmaceutical and Healthcare Marketing 01/2014; 8(2)
Number of pages: 51 Posted: 20 Aug 2006 Last Revised: 05 Sep 2014
Accepted Paper Series
AIG and Cornell University - Samuel Curtis Johnson Graduate School of Management
Downloads 1,308
13.

The Untold EpiPen Story: How Mylan Hiked Prices by Blocking Rivals

102 Cornell Law Review Online 53 (2017)
Number of pages: 20 Posted: 21 Sep 2016 Last Revised: 01 Feb 2017
Accepted Paper Series
Rutgers Law School and Independent
Downloads 1,281
14.

Diversification Strategy in the Pharmaceutical Industry

Number of pages: 20 Posted: 14 Oct 2008
Working Paper Series
"Alexandru Ioan Cuza" University of Iasi, Romania
Downloads 1,140
15.

Has the European Commission Become More Severe in Punishing Cartels? Effects of the 2006 Guidelines

Number of pages: 26 Posted: 11 Jan 2011 Last Revised: 27 Jan 2011
Working Paper Series
Purdue UniversityAmerican Antitrust Institute (AAI)
Downloads 1,118
16.

Patent Trolling — Why Bio & Pharmaceuticals Are at Risk

17 Stan. Tech. L. Rev. 773, 2014, UC Hastings Research Paper No. 93
Number of pages: 40 Posted: 15 Feb 2014 Last Revised: 03 Apr 2016
Accepted Paper Series
UC Law, San Francisco and University of Michigan Law School
Downloads 1,081
17.

Access to Information and the Right to Health: The Human Rights Case for Clinical Trials Transparency

American Journal of Law and Medicine, Vol. 38, pp. 63-112, 2012
Number of pages: 50 Posted: 27 Sep 2011 Last Revised: 06 Mar 2015
Accepted Paper Series
University of Toronto - Faculty of Law and Independent
Downloads 1,034
18.

Global Competitiveness of Indian Pharmaceutical Industry: Trends and Strategies

ISID Working Paper No. 2006/05
Number of pages: 68 Posted: 02 Dec 2009
Working Paper Series
Sardar Patel Institute of Economic & Social ResearchCentral University of Gujarat

Multiple version iconThere are 2 versions of this paper

Downloads 979
19.

Pharmaceutical Marketing: Medical and Industry Biases

Journal of Pharmaceutical Finance, Economics & Policy, Forthcoming
Number of pages: 17 Posted: 04 Feb 2004
Accepted Paper Series
Emory University - Department of Economics
Downloads 979
20.

India’s Pharmaceutical Industry: Global Supply Chain and Governance in the Post- COVID-19 World

Number of pages: 29 Posted: 09 Jun 2020
Working Paper Series
Australian National University (ANU) - Australia South Asia Research Centre (ASARC) and ADFA
Downloads 976
21.

Innovation for the 21st Century: Harnessing the Power of Intellectual Property and Antitrust Law

Oxford University Press, 2009
Number of pages: 16 Posted: 27 Mar 2009
Accepted Paper Series
Rutgers Law School
Downloads 965
22.

Do National Patent Laws Stimulate Domestic Innovation in a Global Patenting Environment? A Cross-Country Analysis of Pharmaceutical Patent Protection, 1978-2002

Review of Economics and Statistics, Vol. 89, No. 3, 2007
Number of pages: 18 Posted: 28 Oct 2007 Last Revised: 08 Jun 2014
Accepted Paper Series
Downloads 948
23.

US Pharma's Financialized Business Model

Institute for New Economic Thinking Working Paper Series No. 60
Number of pages: 27 Posted: 13 Sep 2017
Working Paper Series
The Academic-Industry Research Network, The Academic-Industry Research Network, The Academic-Industry Research Network, The Academic-Industry Research Network and SOAS University of London
Downloads 932
24.

Competition and Regulation Issues in the Pharmaceutical Industry

Number of pages: 401 Posted: 30 Jul 2002
Working Paper Series
Australian Competition and Consumer Commission
Downloads 920
25.

Impact of Profitability, R&D Intensity, and Cash Flow on R&D Expenditure in Pharmaceutical Companies

Number of pages: 13 Posted: 05 May 2011
Working Paper Series
Dexa Medica GroupDexa Laboratories of Biomolecular Sciences, Dexa Medica Group and Atma Jaya Catholic University of Indonesia
Downloads 899
26.

Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health

Journal of Law, Medicine and Ethics, Forthcoming
Number of pages: 30 Posted: 28 Jun 2013 Last Revised: 24 Oct 2015
Accepted Paper Series
Carleton University - School of Public Policy and Administration
Downloads 862
27.

Asymmetric Social Interactions in Physician Prescription Behavior: The Role of Opinion Leaders

Stanford University Graduate School of Business Research Paper No. 1970
Number of pages: 41 Posted: 13 Oct 2006 Last Revised: 30 Jul 2014
Working Paper Series
Stanford University - Graduate School of Business, University of Michigan, Stephen M. Ross School of Business and affiliation not provided to SSRNRutgers, The State University of New Jersey - Rutgers Business School at Newark & New Brunswick
Downloads 857
28.

Two Puzzles Resolved: Of the Schumpeter - Arrow Stalemate and Pharmaceutical Innovation Markets

Iowa Law Review, Vol. 93, 2008
Number of pages: 58 Posted: 09 Apr 2007 Last Revised: 02 Jun 2013
Accepted Paper Series
Rutgers Law School
Downloads 850
29.

A Real-World Analysis of Pharmaceutical Settlements: The Missing Dimension of Product-Hopping

Florida Law Review, Vol. 62, 2010
Number of pages: 28 Posted: 14 Apr 2010 Last Revised: 28 Dec 2013
Working Paper Series
Rutgers Law School
Downloads 844
30.

Using Antitrust Law to Challenge Turing's Daraprim Price Increase

31 Berkeley Technology Law Journal 1379 (2017)
Number of pages: 30 Posted: 29 Jan 2016 Last Revised: 14 Jul 2017
Accepted Paper Series
Rutgers Law School, Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics and Brigham and Women's Hospital/Harvard Medical School
Downloads 842
31.

Cartel Overcharges and Optimal Cartel Fines

Number of pages: 16 Posted: 16 Nov 2007 Last Revised: 20 Nov 2007
Working Paper Series
University of Baltimore - School of Law and Purdue UniversityAmerican Antitrust Institute (AAI)

Multiple version iconThere are 2 versions of this paper

Downloads 826
32.

Complicated Compulsory Licenses: The Waiver/Article31bis 'Solution'

Cynthia M. Ho, ACCESS TO MEDICINE IN THE GLOBAL ECONOMY: INTERNATIONAL AGREEMENTS ON PATENTS AND RELATED RIGHTS, Oxford University Press, April 2011, Loyola University Chicago School of Law Research Paper No. 2011-032
Number of pages: 27 Posted: 05 Sep 2011
Accepted Paper Series
Loyola University of Chicago School of Law
Downloads 817
33.

The Size of Cartel Overcharges: Implications for U.S. and E.U. Fining Policies

Number of pages: 40 Posted: 31 May 2007 Last Revised: 17 Sep 2008
Working Paper Series
Purdue UniversityAmerican Antitrust Institute (AAI) and University of Baltimore - School of Law
Downloads 810
34.

Corporate Restructuring and R&D: A Panel Data Analysis for the Chemical Industry

IGIER Working Paper No. 173
Number of pages: 32 Posted: 01 Mar 2001
Working Paper Series
Duke University - Fuqua School of Business, Scheller College of Business at Georgia Tech and Tilburg University, Department of Finance
Downloads 802
35.

Counterfeit Drugs: The Good, the Bad and the Ugly

Albany Law Journal of Science and Technology, Vol. 15, 2006
Number of pages: 15 Posted: 30 Aug 2006
Accepted Paper Series
Boston University School of Law and affiliation not provided to SSRN
Downloads 801
36.

Consumer Protection in an Era of Globalization

IMPORT SAFETY: REGULATORY GOVERNANCE IN THE GLOBAL ECONOMY, Cary Coglianese, Adam Finkel & David Zaring, eds., University of Pennsylvania Press, 2009 , U of Penn, Inst for Law & Econ Research Paper No. 11-10
Number of pages: 20 Posted: 25 Mar 2011
Accepted Paper Series
University of Pennsylvania Carey Law School, University of Michigan School of Public Health and University of Pennsylvania - Legal Studies Department
Downloads 789
37.

Product Hopping: A New Framework

92 Notre Dame Law Review, 167 (2016)
Number of pages: 65 Posted: 16 Mar 2016 Last Revised: 25 Feb 2017
Accepted Paper Series
Rutgers Law School and Hilliard & Shadowen LLP
Downloads 781
38.

Countervailing Power in Wholesale Pharmaceuticals

Number of pages: 40 Posted: 25 Jul 2001
Working Paper Series
Massachusetts Institute of Technology (MIT) - Department of Economics and Dartmouth College - Department of Economics
Downloads 756
39.

Heterogeneous Learning and the Targeting of Marketing Communication for New Products

Number of pages: 43 Posted: 12 Oct 2006
Working Paper Series
Stanford Graduate School of Business and University of Michigan, Stephen M. Ross School of Business
Downloads 736
40.

Synthesizing Law for Synthetic Biology

Minnesota Journal of Law, Science & Technology, Vol. 11, No. 2, pp. 629-65, 2010
Number of pages: 37 Posted: 25 Jun 2010
Accepted Paper Series
University of Kansas School of Law
Downloads 736
41.

Accounting Profitability and the Political Process: The Case of R&D Accounting in the Pharmaceutical Industry

Number of pages: 42 Posted: 29 Nov 2014 Last Revised: 06 Dec 2024
Working Paper Series
Lancaster University - Department of Accounting and Finance, Heinrich Heine University Dusseldorf - Duesseldorf Institute for Competition Economics (DICE), Lancaster University - Department of Accounting and Finance and WHU - Otto Beisheim School of Management
Downloads 731
42.

Bidil: Race Medicine or Race Marketing?

Health Affairs, October 11, 2005
Number of pages: 9 Posted: 26 Oct 2005
Accepted Paper Series
University of Pennsylvania - Perelman School of Medicine and Northeastern University - School of Law
Downloads 729
43.

Some Accounting and Technical Problems with Antidumping Trade Cases Involving a Transition Economy: A Russian Case Study

Number of pages: 15 Posted: 12 Sep 2003
Working Paper Series
Fayetteville State University - Department of Accounting and Abu Dhabi University - Department of Accounting
Downloads 728
44.

What is 'Business Development'? The Case of Biotechnology

Schmalenbach Business Review, Vol. 59, April 2007
Number of pages: 25 Posted: 04 Aug 2007
Accepted Paper Series
affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 724
45.

Evolution of the Pharmaceutical Industry Bangladesh, 1982 to 2020

Centre for Development Studies, Working Paper 495
Number of pages: 40 Posted: 26 Jan 2021
Working Paper Series
Indian Institute of Management Calcutta
Downloads 720
46.

Effectiveness of Antitrust Sanctions on Modern International Cartels

Journal of Industry, Competition, and Trade 6 (2006): 195-223
Number of pages: 29 Posted: 31 May 2007 Last Revised: 09 Mar 2013
Accepted Paper Series
Purdue UniversityAmerican Antitrust Institute (AAI)
Downloads 718
47.

Internal Deadlines, Drug Approvals, and Safety Problems

Number of pages: 43 Posted: 30 Jul 2019 Last Revised: 15 Sep 2020
Working Paper Series
Harvard University - Business School (HBS), University of Texas at Dallas and Massachusetts Institute of Technology (MIT) - Sloan School of Management

Multiple version iconThere are 2 versions of this paper

Downloads 713
48.

The Effect of Cannabis Legalization on Substance Demand and Tax Revenues

National Tax Journal (2021), 74:1, 107-145
Number of pages: 45 Posted: 25 Mar 2018 Last Revised: 19 Jan 2023
Accepted Paper Series
University of Oregon and Indiana University - Kelley School of Business - Department of Business Economics & Public Policy
Downloads 709
49.

Demand Inertia and the Hidden Impact of Pharmacy Benefit Managers

Management Science, 0[10.1287/mnsc.2021.03331]
Number of pages: 70 Posted: 28 Jan 2019 Last Revised: 18 Nov 2024
Working Paper Series
University of Utah - David Eccles School of Business and Harvard Medical School
Downloads 703
50.

Marketing, Product Differentiation and Competition in the Market for Antiulcer Drugs

HBS Working Paper No. 01-014
Number of pages: 49 Posted: 23 Mar 2006
Working Paper Series
Greylock McKinnon Associates
Downloads 703